March 2011: Oncology Market: Evolution of Treatment, Commercialization and Managed Care

Oncology treatment has evolved over the last decades and has moved away from the evidence based treatment to the value based treatment system. It is also evident the patients and the payers are becoming more influential in deciding the treatment. Due to the varying expectations from the various stake holders the pharmaceutical companies are forced to respond with a risk sharing agreement for treatment using their drugs. Healthcare industry is slow in understanding and responding to the changing environment in the oncology treatment. Pharmaceutical companies are still spending huge amounts on promoting the treatments to physicians whose influence is decreasing with the advent of increasing cost and awareness of the other stakeholders.